{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:15:40Z","timestamp":1793196940052,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012541","name":"Guangdong Innovative and Entrepreneurial Research Team Program","doi-asserted-by":"publisher","award":["2019BT02Y198"],"award-info":[{"award-number":["2019BT02Y198"]}],"id":[{"id":"10.13039\/100012541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012241","name":"Guangzhou Research Collaborative Innovation Projects","doi-asserted-by":"publisher","award":["2024A03J1055"],"award-info":[{"award-number":["2024A03J1055"]}],"id":[{"id":"10.13039\/501100012241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2020B1515120007"],"award-info":[{"award-number":["2020B1515120007"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071859"],"award-info":[{"award-number":["82071859"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371856"],"award-info":[{"award-number":["82371856"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071860"],"award-info":[{"award-number":["82071860"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1515230001"],"award-info":[{"award-number":["2021B1515230001"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.isci.2024.109902","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T11:57:25Z","timestamp":1714737445000},"page":"109902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["YTHDF2 favors protumoral macrophage polarization and implies poor survival outcomes in triple negative breast cancer"],"prefix":"10.1016","volume":"27","author":[{"given":"Hao","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4277-4138","authenticated-orcid":false,"given":"Yandan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.109902_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2024.109902_bib2","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2024.109902_bib3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","article-title":"Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019","volume":"30","author":"Vaduganathan","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2024.109902_bib4","doi-asserted-by":"crossref","first-page":"15182","DOI":"10.1073\/pnas.1922072117","article-title":"Uncoupling DNA damage from chromatin damage to detoxify doxorubicin","volume":"117","author":"Qiao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.109902_bib5","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1111\/febs.15583","article-title":"New insights into the activities and toxicities of the old anticancer drug doxorubicin","volume":"288","author":"van der Zanden","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.isci.2024.109902_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1200\/JCO.2014.56.3296","article-title":"SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer","volume":"33","author":"Budd","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.isci.2024.109902_bib7","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.109902_bib8","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.109902_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2024.109902_bib10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal efect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.109902_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological efects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2024.109902_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/472303a","article-title":"Cancer: Macrophages limit chemotherapy","volume":"472","author":"De Palma","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109902_bib13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2024.109902_bib14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","article-title":"Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses","volume":"73","author":"Mitchem","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2024.109902_bib15","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1038\/s41467-020-18245-7","article-title":"Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells","volume":"11","author":"Candas-Green","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.109902_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.isci.2024.109902_bib17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","article-title":"Present Yourself! By MHC Class I and MHC Class II Molecules","volume":"37","author":"Rock","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.isci.2024.109902_bib18","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a systems understanding of MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2024.109902_bib19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2024.109902_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00262-020-02669-7","article-title":"Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumor heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC","volume":"70","author":"Bao","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.isci.2024.109902_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-022-01558-0","article-title":"Targeting the RNA m6A modification for cancer immunotherapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2024.109902_bib22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0968-0004(02)02189-8","article-title":"YTH: a new domain in nuclear proteins","volume":"27","author":"Stoilov","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.isci.2024.109902_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109902_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.isci.2024.109902_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molcel.2019.07.016","article-title":"N6-Methyladenosine Modification Controls Circular RNA Immunity","volume":"76","author":"Chen","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2024.109902_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ymthe.2022.10.012","article-title":"N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis","volume":"31","author":"Lin","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2024.109902_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215971","article-title":"METTL3-mediated N6-methyladenosine modification and HDAC5\/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance","volume":"553","author":"Zhang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2024.109902_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41590-022-01398-6","article-title":"YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T\u00a0cells","volume":"24","author":"Ma","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2024.109902_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-019-1082-3","article-title":"YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma","volume":"18","author":"Hou","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2024.109902_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","article-title":"Rethinking m6A Readers, Writers, and Erasers","volume":"33","author":"Meyer","year":"2017","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2024.109902_bib31","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.tcb.2020.09.006","article-title":"Lipid Metabolism in Regulation of Macrophage Functions","volume":"30","author":"Yan","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.isci.2024.109902_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/08830185.2014.969421","article-title":"Cellular metabolism and macrophage functional polarization","volume":"34","author":"Zhu","year":"2015","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.isci.2024.109902_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100904","article-title":"Mitochondrial metabolism regulates macrophage biology","volume":"297","author":"Wang","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2024.109902_bib34","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/s41596-020-0330-8","article-title":"Macrophage phagocytosis assay with reconstituted target particles","volume":"15","author":"Joffe","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2024.109902_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41577-023-00848-y","article-title":"Tissue-specific macrophages: how they develop and choreograph tissue biology","volume":"23","author":"Mass","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2024.109902_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/BCJ20210584","article-title":"Macropinocytosis: mechanisms and regulation","volume":"480","author":"Salloum","year":"2023","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2024.109902_bib37","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.109902_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.isci.2024.109902_bib39","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The Broad Spectrum of Human Natural Killer Cell Diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2024.109902_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/2326-6066.CIR-21-0772","article-title":"Spatial Organization and Prognostic Significance of NK and NKT-like Cells via Multimarker Analysis of the Colorectal Cancer Microenvironment","volume":"10","author":"V\u00e4yrynen","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2024.109902_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104467","article-title":"HLA-I-restricted CD8(+) T\u00a0cell immunity may accelerate tumorigenesis in conjunction with VHL inactivation","volume":"25","author":"Park","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.isci.2024.109902_bib42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/mab.2018.0043","article-title":"Enhancing Natural Killer and CD8(+) T Cell-Mediated Anticancer Cytotoxicity and Proliferation of CD8(+) T Cells with HLA-E Monospecific Monoclonal Antibodies","volume":"38","author":"Ravindranath","year":"2019","journal-title":"Monoclon. Antib. Immunodiagn. Immunother."},{"key":"10.1016\/j.isci.2024.109902_bib43","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cell.2020.09.054","article-title":"HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.109902_bib44","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41587-021-00836-4","article-title":"Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4(+) T\u00a0cells","volume":"39","author":"Sugata","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2024.109902_bib45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s42003-022-03057-w","article-title":"Macrophage migration inhibitory factor is overproduced through EGR1 in TET2(low) resting monocytes","volume":"5","author":"Pronier","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.isci.2024.109902_bib46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1124\/molpharm.120.000006","article-title":"Notch1 in Cancer Therapy: Possible Clinical Implications and Challenges","volume":"98","author":"Gharaibeh","year":"2020","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.isci.2024.109902_bib47","article-title":"Low expression of NR1H3 correlates with macrophage infiltration and indicates worse survival in breast cancer","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.isci.2024.109902_bib48","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41590-023-01468-3","article-title":"MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation","volume":"24","author":"Vanneste","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2024.109902_bib49","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41416-018-0110-1","article-title":"Endothelial Akt1 loss promotes prostate cancer metastasis via beta-catenin-regulated tight-junction protein turnover","volume":"118","author":"Gao","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2024.109902_bib50","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-22-1270","article-title":"The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization","volume":"83","author":"Jiang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2024.109902_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virusres.2005.10.014","article-title":"Inhibition of PKR by RNA and DNA viruses","volume":"119","author":"Langland","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.isci.2024.109902_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe9977","article-title":"Mitochondrial translation is required for sustained killing by cytotoxic T\u00a0cells","volume":"374","author":"Lisci","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2024.109902_bib53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","article-title":"NF-kB in development and progression of human cancer","volume":"446","author":"Dolcet","year":"2005","journal-title":"Virchows Arch."},{"key":"10.1016\/j.isci.2024.109902_bib54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/1673-5374.375343","article-title":"Spi1 regulates the microglial\/macrophage inflammatory response via the PI3K\/AKT\/mTOR signaling pathway after intracerebral hemorrhage","volume":"19","author":"Zhang","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.isci.2024.109902_bib55","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41467-021-21186-4","article-title":"Salmonella Typhimurium reprograms macrophage metabolism via T3SS effector SopE2 to promote intracellular replication and virulence","volume":"12","author":"Jiang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.109902_bib56","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/biom13050785","article-title":"The SLIT\/ROBO Pathway in Liver Fibrosis and Cancer","volume":"13","author":"Basha","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2024.109902_bib57","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.cmet.2022.10.010","article-title":"Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production","volume":"34","author":"Yang","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2024.109902_bib58","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41392-021-00761-7","article-title":"XBP1 regulates the protumoral function of tumor-associated macrophages in human colorectal cancer","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2024.109902_bib59","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2021.10.034","article-title":"Wnt signaling pathway in cancer immunotherapy","volume":"525","author":"Zhou","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2024.109902_bib60","first-page":"34","article-title":"RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer","volume":"10","author":"Li","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.isci.2024.109902_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12964-022-00991-4","article-title":"Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer","volume":"20","author":"Carvalho","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.isci.2024.109902_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155272","article-title":"CX3CL1\/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1\/M2 status","volume":"136","author":"Ni","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.isci.2024.109902_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10549-021-06307-3","article-title":"Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer","volume":"189","author":"Ademuyiwa","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.isci.2024.109902_bib64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-020-01650-7","article-title":"COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling","volume":"39","author":"Wang","year":"2020","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2024.109902_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.756085","article-title":"Identification and Validation of CYBB, CD86, and C3AR1 as the Key Genes Related to Macrophage Infiltration of Gastric Cancer","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.isci.2024.109902_bib66","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ymthe.2022.01.006","article-title":"ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m6A-dependent manner","volume":"30","author":"Li","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2024.109902_bib67","article-title":"Single-Cell RNA-Seq Reveals the Promoting Role of Ferroptosis Tendency During Lung Adenocarcinoma EMT Progression","volume":"9","author":"Yao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2024.109902_bib68","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.109902_bib69","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-021-01625-x","article-title":"Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication","volume":"28","author":"Theruvath","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.109902_bib70","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccr.2013.11.007","article-title":"Impeding macrophage entry into hypoxic tumor areas by Sema3A\/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity","volume":"24","author":"Casazza","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2024.109902_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41413-021-00136-2","article-title":"Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases","volume":"9","author":"Polavaram","year":"2021","journal-title":"Bone Res."},{"key":"10.1016\/j.isci.2024.109902_bib72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41467-020-20379-7","article-title":"EGFR\/SRC\/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma","volume":"12","author":"Fang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.109902_bib73","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-020-01267-6","article-title":"YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2024.109902_bib74","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/acsnano.0c00708","article-title":"Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma","volume":"14","author":"Yu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.isci.2024.109902_bib75","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cell.2019.05.035","article-title":"The Cytoplasmic DNA Sensor cGAS Promotes Mitotic Cell Death","volume":"178","author":"Zierhut","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.109902_bib76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1158\/2326-6066.CIR-16-0125","article-title":"Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer","volume":"5","author":"Cullis","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2024.109902_bib77","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.7150\/thno.35972","article-title":"Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2024.109902_bib82","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.109902_bib78","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","article-title":"Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics","volume":"19","author":"Street","year":"2018","journal-title":"BMC Genom."},{"key":"10.1016\/j.isci.2024.109902_bib79","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cellcell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.109902_bib80","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/s41592-023-01938-4","article-title":"SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks","volume":"20","author":"Bravo Gonz\u00e1lez-Blas","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2024.109902_bib81","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","article-title":"Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer","volume":"39","author":"Zhang","year":"2021","journal-title":"Cancer Cell"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224011246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224011246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:25:55Z","timestamp":1782537955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224011246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2589004224011246"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.109902","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YTHDF2 favors protumoral macrophage polarization and implies poor survival outcomes in triple negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.109902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109902"}}